Delivery Order SPE2DR25D6028-SPE2DR26FAUTW
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $4,655.93 to AmerisourceBergen Drug Corp for RECTIV 0.4% Ointment in 30-gram units. This competitive delivery order, issued on September 15, 2025, with completion expected by September 16, 2025, represents a firm fixed-price procurement with no set-aside designation. The award will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $5,303.56 to AmerisourceBergen Drug Corp for the supply of Rectiv 0.4% Ointment in 30-gram units. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of January 29, 2026. The awardee, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs across military and veteran healthcare systems. Performance of this delivery order will take...
- The Defense Logistics Agency awarded a delivery order valued at $1,594.77 to AmerisourceBergen Drug Corp for Rectiv 0.4% Ointment in a 30-gram formulation on January 26, 2026, with an ultimate completion date of January 27, 2026. This firm fixed-price delivery order was awarded on a non-competitive basis and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc. (doing business as AmerisourceBergen),...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 4, 2025, for the supply of Rectiv 0.4% Ointment in 30-gram units. This competitively awarded, non-set-aside contract carries a ceiling value of $3,366.55 and represents a firm fixed-price delivery order with an ultimate completion date of November 5, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp (Cencora, Inc.) on January 28, 2026, for Rectiv 0.4% Ointment in 30-gram units, with a ceiling value of $4,156.87 and a firm fixed-price structure. This non-set-aside award represents a task order under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at $999.99 million through December 2026. The place of performance is located in Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Rectiv 0.4% Ointment in a 30-gram formulation on December 3, 2025, with a firm fixed price ceiling of $9,779.81 and ultimate completion by December 4, 2025. This is a non-set-aside, competitively awarded contract with performance to be conducted at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's broader Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $15,698.77 to AmerisourceBergen Drug Corp for Rectiv 0.4% ointment on December 10, 2025, with an ultimate completion date of January 8, 2026. This firm fixed price delivery order was competitively awarded without set-aside restrictions and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider,...
- This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is for the delivery of RECTIV 0.4% OINTMENT 30GM. The $6,050.87 firm fixed-price delivery order was issued by the Defense Logistics Agency (DLA), a defense agency, and has a completion date of May 26, 2022. The contract is not designated with a set-aside. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 5, 2025, for the supply of Rectiv 0.4% Ointment in 30-gram units, with a ceiling value of $5,673.54. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The order is scheduled for completion by June 6, 2025, and will be fulfilled from AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide RECTIV 0.4% ointment. This $7,587.34 award is part of a larger $999,999,999.00 indefinite delivery contract (IDC) with AmerisourceBergen Drug Corp to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department...
- SPE2DR25D6028Indefinite Delivery Contract
- SPE2DR25D6028-SPE2DR26FAUTWDelivery Order
The Defense Logistics Agency awarded a $13,163.39 firm fixed-price delivery order to AmerisourceBergen Drug Corp for RECTIV 0.4% Ointment on February 3, 2026, with an ultimate completion date of February 4, 2026. This non-set-aside delivery order was performed in Conshohocken, Pennsylvania and represents a single task order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The parent company, Cencora, Inc. (doing business as AmerisourceBergen), holds a significant IDC valued at $999,999,999.00 through December 2031, which serves as the primary vehicle for delivering a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. AmerisourceBergen is a major pharmaceutical distributor providing critical medical commodities to federal healthcare systems, including the Defense Health Agency, U.S. Coast Guard, and Department of Veterans Affairs. RECTIV ointment is a prescription topical medication used in medical treatment, and this delivery order reflects the company's ongoing role as a key supplier for military medical treatment facilities and federal healthcare institutions requiring pharmaceutical and specialty medical products across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $13.2k | 2/2/26 |